Aqsens Health has developed a non-invasive health screening method to detect diseases from saliva, urine and microbiota. At this stage the main focus is on early stage oral cancer, prostate cancer (urine) and screening of IBD (microbiota). The company was founded in 2017 and it has protected its core technology with several patents.